United States · Biotechnology startup
United States · Instylla
Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.
Funding reportedLast round: Series C
Follow Instylla and see its new rounds in your feed.Start following
What company datasets say Instylla raised
Funding, as reported
Reported in all$63Min dollars
Rounds3
Last roundSeries C
Last round dateAug 2023
Investors listed8
On 4 portfolio pages
Investors who name them
Each firm lists Instylla on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Instylla in front of investors. Or tell us what we have wrong.